| 发明名称 |
Unit dose pharmaceutical composition being protease inhibitor |
| 摘要 |
<p>Jednotkov d vka farmaceutick ho prost°edku, kter² je inhibitorem protein zy, obsahuj c (a) terapeuticky · inn mno stv N-terc-butyldekahydro-2-[2(R)-hydroxy-4-fenyl-3(S)-[[N- (2-chinolylkarbonyl)-L-asparaginyl]amino]butyl]-(4aS,8aS)isochinolin-3(S)-karboxamidu nebo jeho farmaceuticky p°ijateln²ch sol nebo ester , v etn jejich farmaceuticky p°ijateln²ch sol a (b) farmaceuticky p°ijateln² nosi obsahuj c monoglycerid mastn kyseliny se st°edn m °et zcem s 8 a 10 atomy uhl ku, p°i em je monoglycerid obsa en v mno stv posta uj c m k rozpuÜt n inhibitoru protein zy./</p> |
| 申请公布号 |
CZ292192(B6) |
申请公布日期 |
2003.08.13 |
| 申请号 |
CZ19970003803 |
申请日期 |
1996.06.04 |
| 申请人 |
F. HOFFMANN-LA ROCHE AG |
发明人 |
BAILEY CAROLE ANNE;FERDINANDO JOSEPHINE CHRISTINE;SHAH NAVNIT |
| 分类号 |
C07D295/08;A61K9/48;A61K31/00;A61K31/18;A61K31/195;A61K31/34;A61K31/341;A61K31/35;A61K31/351;A61K31/38;A61K31/381;A61K31/40;A61K31/403;A61K31/425;A61K31/426;A61K31/44;A61K31/4402;A61K31/4418;A61K31/4427;A61K31/445;A61K31/47;A61K31/472;A61K31/4725;A61K31/495;A61K31/535;A61K31/5375;A61K45/00;A61K45/08;A61K47/14;A61K47/22;A61K47/34;A61P31/12;A61P31/18;A61P37/04;A61P43/00;C07D207/16;C07D209/52;C07D211/60;C07D213/30;C07D213/38;C07D215/48;C07D217/26;C07D277/24;C07D277/28;C07D307/20;C07D309/38;C07D333/32;C07D333/78;C07D401/12;C07D401/14;C07D495/04;(IPC1-7):A61K31/47 |
主分类号 |
C07D295/08 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
|
| 地址 |
|
